PMAIP1 and melanoma: Similar up-regulation of Noxa by ABT-737 plus chemotherapy has been already observed in melanoma cells [13], colorectal cancer cells [38], ovarian carcinoma cells [39] and H196 SCLC cells that are highly resistant to ABT-737 alone [18], thus conferring sensitivity of the cells to this drug.